NCT07408258 2026-04-13
Safety, Pharmacokinetics (PK), and Efficacy of ONC-783 in Advanced Solid Tumors
OncoC4, Inc.
Phase 1 Not yet recruiting
OncoC4, Inc.
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Nanjing Immunophage Biotech Co., Ltd
BeOne Medicines
Cancer Institute and Hospital, Chinese Academy of Medical Sciences